Everest Clinical Research Corporation

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40008615

Informations générales

Localisation

Canada

Northern America

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

01/05/2025

Objectifs à court terme (Near-Term)

Engagement de réduction des émissions à horizon 2029

Statut

Targets set

Classification

1.5°C

Année cible

2029

Progression vers l'objectif79%

2015 (année de référence)2029

Description complète des objectifs

Near-Term Targets: Everest Clinical Research Corporation commits to maintain zero absolute scope 1 and 2 GHG emissions from 2019 through 2029. Everest Clinical Research Corporation also commits to reduce scope 3 GHG emissions 51.6% per USD value added by 2029 from a 2019 base year.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

LEI

549300EVMUDTR6IK3H93

Source : Science Based Targets initiative | Données publiques